Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,242
Out of 4,789 analysts
55
Total ratings
68.09%
Success rate
24.44%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $131.57 | -8.79% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $71.96 | +80.67% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $60.41 | +82.10% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $5.91 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $67.82 | -53.92% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $17.53 | +99.66% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $140.80 | +109.52% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $39.08 | +132.86% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $98.00 | -72.45% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $266.04 | -74.82% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $131.57
Upside: -8.79%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $71.96
Upside: +80.67%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $60.41
Upside: +82.10%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $5.91
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $67.82
Upside: -53.92%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $17.53
Upside: +99.66%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $140.80
Upside: +109.52%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $39.08
Upside: +132.86%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $98.00
Upside: -72.45%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $266.04
Upside: -74.82%